Gabelli Funds’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-146,150
Closed -$3.12M 1125
2024
Q1
$3.12M Buy
+146,150
New +$1.75M 0.02% 558

Gabelli Funds's FUSN Position: Q2 2024 in Review

Gabelli Funds sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 146,150 shares — an estimated $3.12M sold.

Gabelli Funds first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $3.12M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

  • Gabelli Funds reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
  • Gabelli Funds sold 146,150 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $3.12M.
  • Gabelli Funds first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2024 and held it in 1 quarter.
  • Gabelli Funds's Fusion Pharmaceuticals Inc. Common Shares position peaked at $3.12M in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Gabelli Funds's 13F filing for Q2 2024, filed 13 Aug 2024.